Tomoki Ishikawa
Papers
1
Total Citations
27
H-Index
1
About
Dr. Tomoki Ishikawa is a leading health economist and urological outcomes researcher whose work focuses on the cost-effectiveness and economic evaluation of surgical interventions for bladder cancer. His most impactful contribution is a landmark systematic review that meticulously compared the segmental costs of open, laparoscopic, and robot-assisted radical cystectomy, revealing critical insights into the financial implications of adopting robotic surgery. This 2019 study, cited 27 times, was the first to break down costs by phase (e.g., operative, hospitalization), providing surgeons and policymakers with granular data to weigh clinical benefits against economic burdens. Dr. Ishikawa’s research has been instrumental in shifting the conversation from pure technological adoption to value-based care, helping hospitals optimize resource allocation without compromising patient outcomes. His work is widely referenced in health technology assessments and urological guidelines, cementing his reputation as a key voice in surgical cost analysis. For students and researchers, Dr. Ishikawa exemplifies how rigorous economic modeling can inform real-world clinical decisions in an era of rising healthcare costs.
Research Focus
Key Achievements
Top Papers
- 1